Bibby Scientific acquires Electrothermal Engineering
Adds heaters, controllers and reaction stations to product range
Electrothermal, an Essex-based company founded in 1941, is a specialist in precisely controlled heating and cooling applications. The company has an extensive range of products including heaters and controllers for the research and teaching laboratory; reaction stations, which are commonly used by the pharmaceutical industry for optimising reaction conditions; and vehicle-mounted vessels, which have widespread use in military vehicles.
James Heffernan, chief executive of Bibby, said the deal would enhance the company’s position as an industry leader in the manufacture of laboratory products.
‘When coupled with Bibby’s sales channels and extensive complementary product range marketed under the brands Stuart, Techne and Jenway, we believe the new group creates a compelling offering for customers, both current and new,’ he said.
‘We plan to continue to support Electrothermal's reputation as a premium brand offering customers innovative, premium products in each of the markets it serves.’
You may also like
Trending Articles
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing
Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target
BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target